Lyfebulb Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
- Investments
-
9
Lyfebulb General Information
Description
Operator of an online digital platform focused on reducing the burden of chronic disease through the power of the patient. The company bridges the gap between patient communities and the healthcare industry by working directly with patients and care partners to generate insights, build new solutions, and bring revolutionary products to market through education, innovation, and connectivity.
Contact Information
Website
www.lyfebulb.com(Operating Subsidiary)
Corporate Office
- 654 Madison Avenue
- Suite 1501
- New York, NY 10065
- United States
Corporate Office
- 654 Madison Avenue
- Suite 1501
- New York, NY 10065
- United States
Lyfebulb Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lyfebulb Investments (9)
Lyfebulb’s most recent deal was a Grant with Coral Genomics for . The deal was made on 01-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Coral Genomics | 01-Sep-2021 | Grant | Biotechnology | ||
| Nephrosant | 14-May-2021 | Grant | Diagnostic Equipment | ||
| Evolution Devices | 12-Mar-2021 | Grant | Therapeutic Devices | ||
| Oncoheroes Biosciences | 31-Jan-2020 | Grant | Drug Discovery | ||
| BITT (Drug Discovery) | 30-Jan-2020 | Grant | Drug Discovery |
Lyfebulb Exits (4)
Lyfebulb’s most recent exit was on 01-Sep-2021 from Coral Genomics. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Coral Genomics | 01-Sep-2021 | Completed |
|
||
| Nephrosant | 14-May-2021 | Completed |
|
||
| BeCareLink | 10-May-2019 | Completed |
|
||
| MedAngel | 08-Nov-2017 | Grant | Completed |
Lyfebulb FAQs
-
When was Lyfebulb founded?
Lyfebulb was founded in 2014.
-
Where is Lyfebulb headquartered?
Lyfebulb is headquartered in New York, NY.
-
What industry is Lyfebulb in?
Lyfebulb’s primary industry is Media and Information Services (B2B).
-
Is Lyfebulb a private or public company?
Lyfebulb is a Private company.
-
What is Lyfebulb’s current revenue?
The current revenue for Lyfebulb is .
-
When was Lyfebulb acquired?
Lyfebulb was acquired on 05-Mar-2024.
-
Who acquired Lyfebulb?
Lyfebulb was acquired by Patient Care America.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process